TYSON TIMOTHY 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
TYSON TIMOTHY
Director
Transactions
- Award
Common Stock
2022-09-16+8,000→ 8,000 total - Award
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 totalExercise: $7.35Exp: 2032-09-15→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022.